Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinic
paradigm_report_works_22122023
10.2217_nmt-2021-0055
7
4
2022
203
214
article
12
Neurodegenerative Disease Management
Informa UK Limited
Imane Frouni
Philippe Huot
False
10.2217/nmt-2021-0055
Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinic
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our
Terms of Service and Privacy Policy.